Metastases, Neoplasm
26
1
1
17
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
19.2%
5 terminated out of 26 trials
77.3%
-9.2% vs benchmark
23%
6 trials in Phase 3/4
18%
3 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (26)
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors
Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)
Surgical Treatment of Pancreatic RCC Metastases
Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases
Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)
ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer
A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies
This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer
Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)
A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer
Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients
Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole
A Study in Patients With Advanced or Metastatic Cancer
Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer
Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.
Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma